We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Advertisement

IONTAS and FairJourney Biologics Enter Antibody Discovery Agreement With Quell Therapeutics

Product News   Mar 08, 2021

 
IONTAS and FairJourney Biologics Enter Antibody Discovery Agreement With Quell Therapeutics

Credit: IONTAS

FURTHER INFORMATION
 
 
Advertisement
 

Related Product News

FairJourney Biologics Enters Next-Generation Antibody Discovery Collaboration With Argenx

Product News

FairJourney Biologics S.A and IONTAS Limited have announced a collaboration with argenx to harness IONTAS’ proprietary mammalian display technology. The goal of the collaboration is to explore diverse panels of novel antibody candidates, with the potential to advance select candidates into the argenx discovery pipeline.

READ MORE

Lonza Celebrates 20th Anniversary of Nucleofector Cell Transfection Platform

Product News

2021 marks the 20th anniversary of Lonza’s Nucleofector™ Technology, the industry’s leading non-viral cell transfection method, which has been cited more than 10,000 times, including in research by two Nobel Laureates.

READ MORE

Bethyl Wins the CiteAb Researchers’ Choice Award

Product News

Bethyl Laboratories, Inc., has won the 2021 CiteAb Researchers’ Choice Award. The CiteAb awards recognize both suppliers and individuals who make notable contributions in the life sciences reagent sector.

READ MORE

Like what you just read? You can find similar content on the communities below.

Biopharma Immunology & Microbiology

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE